{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:21:02Z","timestamp":1780521662541,"version":"3.54.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Polish National Science Center","award":["2019\/35\/B\/NZ5\/02398"],"award-info":[{"award-number":["2019\/35\/B\/NZ5\/02398"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s43440-025-00813-7","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T05:28:29Z","timestamp":1765517309000},"page":"277-291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In silico assessment of neuromuscular blocking agents and fluoroquinolones as ligands of the Mas-related G protein-coupled receptor X2"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1461-1346","authenticated-orcid":false,"given":"Hubert","family":"Rybka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9675-7790","authenticated-orcid":false,"given":"Alicja","family":"Dziadowiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2743-6934","authenticated-orcid":false,"given":"Mateusz","family":"Kwitniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9518-4815","authenticated-orcid":false,"given":"Daniel","family":"Bulanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4718-8082","authenticated-orcid":false,"given":"Rados\u0142aw","family":"Kitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-0188","authenticated-orcid":false,"given":"Grzegorz","family":"Por\u0119bski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"813_CR1","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1111\/all.16576","volume":"80","author":"C Mayorga","year":"2025","unstructured":"Mayorga C, Fernandez-Santamaria R, \u00c7elik GE, Labella M, Murdaca G, Sokolowska M, et al. Endotypes in immune mediated drug reactions: present and future of relevant Biomarkers. An EAACI task force report. Allergy. 2025;80:1831\u201347. https:\/\/doi.org\/10.1111\/all.16576.","journal-title":"Allergy"},{"key":"813_CR2","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/jdv.20249","volume":"39","author":"M Kumar","year":"2025","unstructured":"Kumar M, Choi YG, Wong T, Li PH, Chow BKC. Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases. J Eur Acad Dermatol Venereol. 2025;39:476\u201386. https:\/\/doi.org\/10.1111\/jdv.20249.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"813_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/all.15933","volume":"79","author":"C Mayorga","year":"2024","unstructured":"Mayorga C, Ariza A, Mu\u00f1oz-Cano R, Sabato V, Do\u00f1a I, Torres MJ. Biomarkers of immediate drug hypersensitivity. Allergy. 2024;79:601\u201312. https:\/\/doi.org\/10.1111\/all.15933.","journal-title":"Allergy"},{"key":"813_CR4","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/all.15889","volume":"78","author":"M Jutel","year":"2023","unstructured":"Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, et al. Nomenclature of allergic diseases and hypersensitivity reactions: adapted to modern needs: an EAACI position paper. Allergy. 2023;78:2851\u201374. https:\/\/doi.org\/10.1111\/all.15889.","journal-title":"Allergy"},{"key":"813_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"BD McNeil","year":"2015","unstructured":"McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, et al. Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature. 2015;519:237\u201341. https:\/\/doi.org\/10.1038\/nature14022.","journal-title":"Nature"},{"key":"813_CR6","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu R, Hu S, Zhang Y, Che D, Cao J, Wang J, et al. Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Int Immunopharmacol. 2019;70:417\u201327. https:\/\/doi.org\/10.1016\/j.intimp.2019.02.001.","journal-title":"Int Immunopharmacol"},{"key":"813_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/cells10010156","volume":"10","author":"C Chompunud Na Ayudhya","year":"2021","unstructured":"Chompunud Na Ayudhya C, Amponnawarat A, Roy S, Oskeritzian CA, Ali H. MRGPRX2 activation by rocuronium: insights from studies with human skin mast cells and missense variants. Cells. 2021;10:156. https:\/\/doi.org\/10.3390\/cells10010156.","journal-title":"Cells"},{"key":"813_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/ACI.0000000000001001","volume":"24","author":"B Olivieri","year":"2024","unstructured":"Olivieri B, Ghilarducci A, Nalin F, Bonadonna P. Mast cell conditions and drug allergy: when to suspect and how to manage. Curr Opin Allergy Clin Immunol. 2024;24:195\u2013202. https:\/\/doi.org\/10.1097\/ACI.0000000000001001.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"813_CR9","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.3389\/fimmu.2018.03027","volume":"9","author":"G Porebski","year":"2018","unstructured":"Porebski G, Kwiecien K, Pawica M, Kwitniewski M, Mas-Related G, Protein-Coupled. Receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol. 2018;9:3027. https:\/\/doi.org\/10.3389\/fimmu.2018.03027.","journal-title":"Front Immunol"},{"key":"813_CR10","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1111\/all.13765","volume":"74","author":"WJ Pichler","year":"2019","unstructured":"Pichler WJ. Immune pathomechanism and classification of drug hypersensitivity. Allergy. 2019;74:1457\u201371. https:\/\/doi.org\/10.1111\/all.13765.","journal-title":"Allergy"},{"key":"813_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nchembio.2334","volume":"13","author":"K Lansu","year":"2017","unstructured":"Lansu K, Karpiak J, Liu J, Huang XP, McCorvy JD, Kroeze WK, et al. In Silico design of novel probes for the atypical opioid receptor MRGPRX2. Nat Chem Biol. 2017;13:529\u201336. https:\/\/doi.org\/10.1038\/nchembio.2334.","journal-title":"Nat Chem Biol"},{"key":"813_CR12","doi-asserted-by":"publisher","first-page":"16146","DOI":"10.1038\/s41598-020-72819-5","volume":"10","author":"E Hamamura-Yasuno","year":"2020","unstructured":"Hamamura-Yasuno E, Iguchi T, Kumagai K, Tsuchiya Y, Mori K. Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions. Sci Rep. 2020;10:16146. https:\/\/doi.org\/10.1038\/s41598-020-72819-5.","journal-title":"Sci Rep"},{"key":"813_CR13","doi-asserted-by":"publisher","first-page":"108193","DOI":"10.1016\/j.jsb.2025.108193","volume":"217","author":"P Maier","year":"2025","unstructured":"Maier P, Macht M, Beck S, Kolkhir P, Babina M, Kremer AE, et al. MRGPRX2 ligandome: molecular simulations reveal three categories of ligand-receptor interactions. J Struct Biol. 2025;217:108193. https:\/\/doi.org\/10.1016\/j.jsb.2025.108193.","journal-title":"J Struct Biol"},{"key":"813_CR14","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s43440-025-00748-z","volume":"77","author":"SK Kordylewski","year":"2025","unstructured":"Kordylewski SK, Bugno R, Podlewska S. Residence time in drug discovery: current insights and future perspectives. Pharmacol Rep. 2025;77:851\u201373. https:\/\/doi.org\/10.1007\/s43440-025-00748-z.","journal-title":"Pharmacol Rep"},{"key":"813_CR15","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","volume":"600","author":"C Cao","year":"2021","unstructured":"Cao C, Kang HJ, Singh I, Chen H, Zhang C, Ye W, et al. Structure, function and Pharmacology of human itch GPCRs. Nature. 2021;600:170\u20135. https:\/\/doi.org\/10.1038\/s41586-021-04126-6.","journal-title":"Nature"},{"key":"813_CR16","doi-asserted-by":"publisher","first-page":"167995","DOI":"10.1016\/j.jmb.2023.167995","volume":"435","author":"SJ Park","year":"2023","unstructured":"Park SJ, Kern N, Brown T, Lee J, Im W, CHARMM-GUI PDB, Manipulator. Various PDB structural modifications for biomolecular modeling and simulation. J Mol Biol. 2023;435:167995. https:\/\/doi.org\/10.1016\/j.jmb.2023.167995.","journal-title":"J Mol Biol"},{"issue":"1","key":"813_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13321-019-0358-3","volume":"11","author":"PJ Ropp","year":"2019","unstructured":"Ropp PJ, Spiegel JO, Walker JL, Green H, Morales GA, Milliken KA, et al. Gypsum-DL: an open-source program for Preparing small-molecule libraries for structure-based virtual screening. J Cheminform. 2019;11(1):34. https:\/\/doi.org\/10.1186\/s13321-019-0358-3.","journal-title":"J Cheminform"},{"key":"813_CR18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13321-025-00973-x","volume":"17","author":"AT McNutt","year":"2025","unstructured":"McNutt AT, Li Y, Meli R, Aggarwal R, Koes DR. GNINA 1.3: the next increment in molecular Docking with deep learning. J Cheminform. 2025;17:28. https:\/\/doi.org\/10.1186\/s13321-025-00973-x.","journal-title":"J Cheminform"},{"key":"813_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1","author":"MJ Abraham","year":"2015","unstructured":"Abraham MJ, Murtola T, Schulz R, P\u00e1ll S, Smith JC, Hess B, Lindahl E. GROMACS: high performance molecular simulations through Multi-Level parallelism from laptops to supercomputers. SoftwareX. 2015;1:19\u201325.","journal-title":"SoftwareX"},{"key":"813_CR20","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1021\/acs.jctc.8b01066","volume":"15","author":"J Lee","year":"2019","unstructured":"Lee J, Patel DS, St\u00e5hle J, Park SJ, Kern NR, Kim S, et al. CHARMM-GUI membrane builder for complex biological membrane simulations with glycolipids and lipoglycans. J Chem Theory Comput. 2019;15:775\u201386. https:\/\/doi.org\/10.1021\/acs.jctc.8b01066.","journal-title":"J Chem Theory Comput"},{"key":"813_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jcc.21367","volume":"31","author":"K Vanommeslaeghe","year":"2010","unstructured":"Vanommeslaeghe K, Hatcher E, Acharya C, Kundu S, Zhong S, Shim J, et al. CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. J Comput Chem. 2010;31:671\u201390. https:\/\/doi.org\/10.1002\/jcc.21367.","journal-title":"J Comput Chem"},{"key":"813_CR22","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/jcc.24829","volume":"38","author":"S Kim","year":"2017","unstructured":"Kim S, Lee J, Jo S, Brooks CL 3rd, Lee HS, Im W. CHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules. J Comput Chem. 2017;38:1879\u201386. https:\/\/doi.org\/10.1002\/jcc.24829.","journal-title":"J Comput Chem"},{"key":"813_CR23","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1002\/jcc.21787","volume":"32","author":"N Michaud-Agrawal","year":"2011","unstructured":"Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32:2319\u201327. https:\/\/doi.org\/10.1002\/jcc.21787.","journal-title":"J Comput Chem"},{"key":"813_CR24","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"ML Waskom","year":"2021","unstructured":"Waskom ML, Seaborn. Statistical data visualization. J Open Source Softw. 2021;6:3021. https:\/\/doi.org\/10.21105\/joss.03021.","journal-title":"J Open Source Softw"},{"key":"813_CR25","unstructured":"The PyMOL Molecular Graphics System, Version 3.0; Schr\u00f6dinger, LLC."},{"key":"813_CR26","doi-asserted-by":"publisher","unstructured":"Vald\u00e9s-Tresanco MS, Vald\u00e9s-Tresanco ME, Valiente PA, Moreno E, gmx_MMPBSA:. A new tool to perform End-State free energy calculations with GROMACS. J Chem Theory Comput. 2021;17:6281\u201391. https:\/\/doi.org\/10.1021\/acs.jctc.1c00645.","DOI":"10.1021\/acs.jctc.1c00645"},{"key":"813_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13321-021-00548-6","volume":"13","author":"C Bouysset","year":"2021","unstructured":"Bouysset C, Fiorucci S. ProLIF: a library to encode molecular interactions as fingerprints. J Cheminform. 2021;13:72. https:\/\/doi.org\/10.1186\/s13321-021-00548-6.","journal-title":"J Cheminform"},{"key":"813_CR28","doi-asserted-by":"publisher","first-page":"110631","DOI":"10.1016\/j.intimp.2023.110631","volume":"122","author":"P Kwiecinska","year":"2023","unstructured":"Kwiecinska P, Kwitniewski M, Kwiecien K, Morytko A, Majewski P, Pocalun N, et al. Secretory leukocyte protease inhibitor modulates Fc\u03b5RI-dependent but not Mrgprb2-dependent mastocyte function in psoriasis. Int Immunopharmacol. 2023;122:110631. https:\/\/doi.org\/10.1016\/j.intimp.2023.110631.","journal-title":"Int Immunopharmacol"},{"key":"813_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im0738s91","author":"HS Kuehn","year":"2010","unstructured":"Kuehn HS, Radinger M, Gilfillan AM. Measuring mast cell mediator release. Curr Protoc Immunol. 2010. https:\/\/doi.org\/10.1002\/0471142735.im0738s91. Chap. 7, Unit 7.38.","journal-title":"Curr Protoc Immunol"},{"key":"813_CR30","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1017\/s0265021502000777","volume":"19","author":"V Fodale","year":"2002","unstructured":"Fodale V, Santamaria LB. Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol. 2002;19:466\u201373. https:\/\/doi.org\/10.1017\/s0265021502000777.","journal-title":"Eur J Anaesthesiol"},{"key":"813_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/112_2020_53","volume":"179","author":"YN Mi","year":"2021","unstructured":"Mi YN, Ping NN, Cao YX. Ligands and signaling of Mas-Related G Protein-Coupled Receptor-X2 in mast cell activation. Rev Physiol Biochem Pharmacol. 2021;179:139\u201388. https:\/\/doi.org\/10.1007\/112_2020_53.","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"10","key":"813_CR32","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1111\/all.13820","volume":"74","author":"LH Garvey","year":"2019","unstructured":"Garvey LH, Ebo DG, Mertes PM, Dewachter P, Garcez T, Kopac P, Laguna JJ, Chiriac AM, Terreehorst I, Voltolini S, Scherer K. An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactions. Allergy. 2019;74(10):1872\u201384. https:\/\/doi.org\/10.1111\/all.13820.","journal-title":"Allergy"},{"key":"813_CR33","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/pds.3857","volume":"24","author":"B Sachs","year":"2015","unstructured":"Sachs B, Fischer-Barth W, Merk HF. Reporting rates for severe hypersensitivity reactions associated with prescription-only drugs in outpatient treatment in Germany. Pharmacoepidemiol Drug Saf. 2015;24:1076\u201384. https:\/\/doi.org\/10.1002\/pds.3857.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"813_CR34","doi-asserted-by":"publisher","first-page":"e89362","DOI":"10.1172\/jci.insight.89362","volume":"1","author":"E Azimi","year":"2016","unstructured":"Azimi E, Reddy VB, Shade KC, Anthony RM, Talbot S, Pereira PJS, et al. Dual action of neurokinin-1 antagonists on Mas-related GPCRs. JCI Insight. 2016;1:e89362. https:\/\/doi.org\/10.1172\/jci.insight.89362.","journal-title":"JCI Insight"},{"key":"813_CR35","doi-asserted-by":"publisher","first-page":"668962","DOI":"10.3389\/fimmu.2021.668962","volume":"12","author":"J Elst","year":"2021","unstructured":"Elst J, Maurer M, Sabato V, Faber MA, Bridts CH, Mertens C, et al. Novel insights on MRGPRX2-Mediated hypersensitivity to neuromuscular blocking agents and fluoroquinolones. Front Immunol. 2021;12:668962. https:\/\/doi.org\/10.3389\/fimmu.2021.668962.","journal-title":"Front Immunol"},{"key":"813_CR36","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.jaci.2023.01.029","volume":"151","author":"K Kunimura","year":"2023","unstructured":"Kunimura K, Akiyoshi S, Uruno T, Matsubara K, Sakata D, Morino K, et al. DOCK2 regulates MRGPRX2\/B2-mediated mast cell degranulation and drug-induced anaphylaxis. J Allergy Clin Immunol. 2023;151:1585\u2013e15949. https:\/\/doi.org\/10.1016\/j.jaci.2023.01.029.","journal-title":"J Allergy Clin Immunol"},{"key":"813_CR37","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/cea.13801","volume":"51","author":"NA Fernandopulle","year":"2021","unstructured":"Fernandopulle NA, Zhang SS, Soeding PF, Mackay GA. MRGPRX2 activation in mast cells by neuromuscular blocking agents and other agonists: modulation by Sugammadex. Clin Exp Allergy. 2021;51:685\u201395. https:\/\/doi.org\/10.1111\/cea.13801.","journal-title":"Clin Exp Allergy"},{"key":"813_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.18176\/jiaci.0557","volume":"31","author":"J Elst","year":"2021","unstructured":"Elst J, Sabato V, Faber MA, Bridts CH, Mertens C, Van Houdt M, et al. MRGPRX2 and immediate drug hypersensitivity: insights from cultured human mast cells. J Investig Allergol Clin Immunol. 2021;31:489\u201399. https:\/\/doi.org\/10.18176\/jiaci.0557.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"813_CR39","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","volume":"8","author":"A Navin\u00e9s-Ferrer","year":"2018","unstructured":"Navin\u00e9s-Ferrer A, Serrano-Candelas E, Lafuente A, Mu\u00f1oz-Cano R, Mart\u00edn M, Gastaminza G. MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep. 2018;8:11628. https:\/\/doi.org\/10.1038\/s41598-018-29965-8.","journal-title":"Sci Rep"},{"key":"813_CR40","doi-asserted-by":"publisher","first-page":"113003","DOI":"10.1016\/j.jim.2021.113003","volume":"492","author":"J Elst","year":"2021","unstructured":"Elst J, Sabato V, van der Poorten MM, Faber M, Van Gasse AL, De Puysseleyr LP, et al. Peripheral blood cultured mast cells: phenotypic and functional outcomes of different culture protocols. J Immunol Methods. 2021;492:113003. https:\/\/doi.org\/10.1016\/j.jim.2021.113003.","journal-title":"J Immunol Methods"},{"key":"813_CR41","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/all.15270","volume":"77","author":"M Babina","year":"2022","unstructured":"Babina M, Wang Z, Li Z, et al. Fc\u03b5RI- and MRGPRX2-evoked acute degranulation responses are fully additive in human skin mast cells. Allergy. 2022;77:1906\u20139. https:\/\/doi.org\/10.1111\/all.15270.","journal-title":"Allergy"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00813-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00813-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00813-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:13:34Z","timestamp":1768342414000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00813-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00813-7","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}